Idera Pharmaceuticals, Inc. – NASDAQ:IDRA

Idera Pharmaceuticals stock price today

$0.425

Idera Pharmaceuticals stock price monthly change

+51.79%
month

Idera Pharmaceuticals stock price quarterly change

-0.68%
quarter

Idera Pharmaceuticals stock price yearly change

-27.73%
year

Idera Pharmaceuticals key metrics

Market Cap
 N/A
Enterprise value
 N/A
P/E
 -0.07
EV/Sales
 -506.89
EV/EBITDA
 1.10
Price/Sales
 27.18
Price/Book
 0.06
PEG ratio
 N/A
EPS
 -6.01
Revenue
 N/A
EBITDA
 -45.91M
Income
 -41.04M
Revenue Q/Q
 N/A
Revenue Y/Y
 N/A
Profit margin
 -34087.76%
Oper. margin
 -46928.57%
Gross margin
 -5687.76%
EBIT margin
 -46928.57%
EBITDA margin
 N/A

Get more financial ratios!

  • Every financial ratio you might need

  • 10 years history

  • Forward ratios (Analysts estimates)

Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Idera Pharmaceuticals stock price history

Idera Pharmaceuticals stock forecast

Idera Pharmaceuticals financial statements

Profit Margin

Idera Pharmaceuticals, Inc. (NASDAQ:IDRA): Profit margin
Jun 2022 0 -5.34M
Sep 2022 49K -3.09M -6324.49%
Dec 2022 -49K -10.73M 21900%
Mar 2023 0 -21.86M
IDRA income statement history

Debt to Assets

Idera Pharmaceuticals, Inc. (NASDAQ:IDRA): Debt to assets
Jun 2022 26306000 5.17M 19.67%
Sep 2022 103682000 82.91M 79.97%
Dec 2022 101107000 62.17M 61.49%
Mar 2023 78492000 55.94M 71.27%
IDRA balance sheet history

Cash Flow

Idera Pharmaceuticals, Inc. (NASDAQ:IDRA): Cash Flow
Jun 2022 -3.52M 0 12K
Sep 2022 -3.19M 5.48M 31K
Dec 2022 -13.20M 0 -1.54M
Mar 2023 -9.85M 0 -74K
IDRA cash flow history

Idera Pharmaceuticals alternative data

Idera Pharmaceuticals
Employees

Idera Pharmaceuticals, Inc. (NASDAQ:IDRA): Employee count
Aug 2023 13
Sep 2023 13
Oct 2023 13
Nov 2023 13
Dec 2023 13
Jan 2024 13
Feb 2024 13
Apr 2024 13
May 2024 13
Jun 2024 13
Jul 2024 13

Idera Pharmaceuticals other data

Idera Pharmaceuticals
Insider Trading

Idera Pharmaceuticals, Inc. (NASDAQ:IDRA): Insider trades (number of shares)
Period Buy Sel
May 2023 26965 264324
Jul 2023 0 5818
Aug 2023 0 3334
Transaction Date Insider Security Shares Price per share Total value Source
Sale
GOWEN MAXINE director
 Common Stock 51 $0.51 $26
Sale
MILANO VINCENT director Common Stock 3,283 $0.53 $1,750
Sale
PILLAR INVEST CORP 10 percent owner
 Common Stock 2,213 $1.54 $3,408
Sale
PILLAR INVEST CORP 10 percent owner
 Common Stock 3,605 $1.58 $5,696
Sale
CHOPRA ATUL 10 percent owner
 Common Stock, $0.001 per share 257 $1.31 $337
Sale
CHOPRA ATUL 10 percent owner
 Common Stock, $0.001 per share 1,049 $1.32 $1,385
Sale
CHOPRA ATUL 10 percent owner
 Common Stock, $0.001 per share 15,172 $1.33 $20,179
Sale
CHOPRA ATUL 10 percent owner
 Common Stock, $0.001 per share 6,181 $1.34 $8,283
Sale
CHOPRA ATUL 10 percent owner
 Common Stock, $0.001 per share 601 $1.35 $811
Sale
CHOPRA ATUL 10 percent owner
 Common Stock, $0.001 per share 1,540 $1.37 $2,110
IDRA insider trading transactions

Idera Pharmaceuticals
Patents

Patent
Application
Filling date: 6 Dec 2021 Issue date: 24 Mar 2022
Application
Filling date: 18 Oct 2019 Issue date: 4 Nov 2021
Application
Filling date: 9 Apr 2021 Issue date: 14 Oct 2021
Application
Filling date: 14 Sep 2020 Issue date: 25 Feb 2021
Application
Filling date: 21 Oct 2020 Issue date: 11 Feb 2021
Grant
Filling date: 30 Aug 2019 Issue date: 17 Nov 2020
Grant
Filling date: 30 Aug 2019 Issue date: 15 Sep 2020
Application
Filling date: 30 Aug 2019 Issue date: 7 May 2020
Application
Filling date: 13 Dec 2019 Issue date: 2 Apr 2020
Application
Filling date: 30 Aug 2019 Issue date: 20 Feb 2020
IDRA patents

Idera Pharmaceuticals
Earnings Call Transcripts

Quarter Transcript
Q2 2019 8 Aug 2019 Q2 2019 Earnings Call Transcript
Q1 2016 10 May 2016 Q1 2016 Earnings Call Transcript
Q3 2014 12 Nov 2014 Q3 2014 Earnings Call Transcript
Q2 2014 12 Aug 2014 Q2 2014 Earnings Call Transcript
IDRA earnings call transcripts

Frequently Asked Questions (FAQ)

  • What's the price of Idera Pharmaceuticals stock today?

    One share of Idera Pharmaceuticals stock can currently be purchased for approximately $0.43.

  • When is Idera Pharmaceuticals's next earnings date?

    Unfortunately, Idera Pharmaceuticals's (IDRA) next earnings date is currently unknown.

  • Does Idera Pharmaceuticals pay dividends?

    No, Idera Pharmaceuticals does not pay dividends.

  • What is Idera Pharmaceuticals's stock symbol?

    Idera Pharmaceuticals, Inc. is traded on the NASDAQ under the ticker symbol "IDRA".

  • What is Idera Pharmaceuticals's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Idera Pharmaceuticals?

    Shares of Idera Pharmaceuticals can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Idera Pharmaceuticals's key executives?

    Idera Pharmaceuticals's management team includes the following people:

    • Mr. Bryant David Lim Senior Vice President, Gen. Counsel & Corporation Sec.(age: 54, pay: $514,230)
    • Mr. John J. Kirby Senior Vice President & Chief Financial Officer(age: 53, pay: $513,970)
    • Mr. Vincent J. Milano Pres, Chief Executive Officer & Director(age: 61, pay: $347,710)

  • How many employees does Idera Pharmaceuticals have?

    As Jul 2024, Idera Pharmaceuticals employs 13 workers.

  • When Idera Pharmaceuticals went public?

    Idera Pharmaceuticals, Inc. is publicly traded company for more then 29 years since IPO on 25 Jan 1996.

  • What is Idera Pharmaceuticals's official website?

    The official website for Idera Pharmaceuticals is iderapharma.com.

  • Where are Idera Pharmaceuticals's headquarters?

    Idera Pharmaceuticals is headquartered at 505 Eagleview Boulevard, Exton, PA.

  • How can i contact Idera Pharmaceuticals?

    Idera Pharmaceuticals's mailing address is 505 Eagleview Boulevard, Exton, PA and company can be reached via phone at +48 43481600.

Idera Pharmaceuticals company profile:

Idera Pharmaceuticals, Inc.

iderapharma.com
Exchange:

NASDAQ

Full time employees:

13

Industry:

Biotechnology

Sector:

Healthcare

Idera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating solid tumors, squamous cell carcinoma of the head and neck, and colorectal cancer. The company has a collaboration agreement with Bristol-Meyers Squibb. Idera Pharmaceuticals, Inc. was incorporated in 1989 and is headquartered in Exton, Pennsylvania.

+48 43481600
505 Eagleview Boulevard
Exton, PA 19341

CIK: 0000861838
ISIN: US45168K4058
CUSIP: 45168K405